- Investing Ideas
- /
- Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
2 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥12.7b
Tibet Rhodiola Pharmaceutical Holding Co.
New
600211
CN¥39.53
7D
10.9%
1Y
10.0%
HangzhouS MedTech
Market Cap: CN¥5.6b
Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China.
New
688581
CN¥69.01
7D
-2.3%
1Y
15.4%
Well Lead Medical
Market Cap: CN¥3.6b
Engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide.
603309
CN¥12.36
7D
3.5%
1Y
3.6%
Page 1 of 1